Emerging Markets: July Monthly Commentary

2 minutes read time A positive relative performance of 0.4% in March has led us to finish the first quarter of 2024 with an outperformance of 2.3% against the MSCI Emerging Markets index.

Emerging Markets Income: June Monthly Commentary

2 minutes read time April proved to be the first month in a while that we saw some meaningful rotation in the geographic performance of the fund. Our weakest markets were Taiwan, Mexico and Brazil, largely triggered by resurgent concerns over the path of US interest rates. Our top performers were in China/Hong Kong, Chile and Greece.

Emerging Markets: June Monthly Commentary

3 minutes read time A positive relative performance of 0.4% in March has led us to finish the first quarter of 2024 with an outperformance of 2.3% against the MSCI Emerging Markets index.

Emerging Markets Income: May Monthly Commentary

2 minutes read time April proved to be the first month in a while that we saw some meaningful rotation in the geographic performance of the fund. Our weakest markets were Taiwan, Mexico and Brazil, largely triggered by resurgent concerns over the path of US interest rates. Our top performers were in China/Hong Kong, Chile and Greece.

Emerging Markets: May Monthly Commentary

2 minutes read time A positive relative performance of 0.4% in March has led us to finish the first quarter of 2024 with an outperformance of 2.3% against the MSCI Emerging Markets index.

Emerging Markets Income: April Monthly Commentary

2 minutes read time April proved to be the first month in a while that we saw some meaningful rotation in the geographic performance of the fund. Our weakest markets were Taiwan, Mexico and Brazil, largely triggered by resurgent concerns over the path of US interest rates. Our top performers were in China/Hong Kong, Chile and Greece.

Emerging Markets: April Monthly Commentary

2 minutes read time During April the fund underperformed the MSCI Emerging Markets index by 1.8%. The largest relative detractor was China, in particular due to some weak market closes on US listed ADRs at the end of the month.